KraneShares Emerging Markets Healthcare Index ETF
KMED
KMED was delisted on the 18th of October, 2023.
3 hedge funds and large institutions have $411K invested in KraneShares Emerging Markets Healthcare Index ETF in 2023 Q1 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.
47% more capital invested
Capital invested by funds: $280K → $411K (+$131K)
0% more funds holding
Funds holding: 3 → 3 (0)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$154K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$4.72K |
KMED Hedge Fund Activity: Q1 2023 in Review
3 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in KraneShares Emerging Markets Healthcare Index ETF (KMED) for Q1 2023, worth a combined $411K — up 47% from $280K a quarter earlier.
Fund positioning in KMED was balanced in Q1 2023: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 1 trimmed.
The largest buyer was Jane Street, adding an estimated $154K. The largest seller was UBS Group, cutting an estimated $4.72K.
- 3 institutional investors held KraneShares Emerging Markets Healthcare Index ETF (KMED) as of Q1 2023, unchanged from Q4 2022.
- Funds reported $411K of KraneShares Emerging Markets Healthcare Index ETF stock for Q1 2023, up 47% quarter-over-quarter.
- 0 funds opened new KraneShares Emerging Markets Healthcare Index ETF positions in Q1 2023 and 0 closed out.
- The largest KraneShares Emerging Markets Healthcare Index ETF buyer in Q1 2023 was Jane Street, an estimated $154K added.
- The largest KraneShares Emerging Markets Healthcare Index ETF seller in Q1 2023 was UBS Group, an estimated $4.72K sold.
Based on aggregated 13F filings for Q1 2023.